KAATSU Global’s BFR Protocols for Serious Indications: FDA Clearance Challenges and the Marketing–Medicine Boundary
A systematic review of KAATSU health-consideration pages reveals standardized Cycle-Mode protocols applied uniformly across five serious indications. This article evaluates scientific evidence, patient-safety risks, and regulatory hurdles—including the low likelihood of FDA clearance under current conditions—while highlighting the need for clearer boundaries between commercial promotion and clinical standards.